Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Canadian Agency for Drugs and Technologies in Health (CADTH). Long-term sustained clinical remission after stopping first-line anti-TNF agents in patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitis: clinical effectiveness. Ottawa: Canadian Agency for Drugs and Technologies in Health (CADTH). Rapid Response - Summary of Abstracts. 2014 Authors' conclusions Two randomized controlled trials (RCTs) and one non-randomized study were identified regarding the long-term clinical effectiveness (not necessarily clinical remission) in patients with RA who remain on MTX after using an anti-TNF agent plus MTX as first-line treatment. Indexing Status Subject indexing assigned by CRD MeSH Arthritis; Dermatology; Methotrexate; Methotrexates; Spondylitis Language Published English Country of organisation Canada English summary An English language summary is available. Address for correspondence Canadian Agency for Drugs and Technologies in Health (CADTH), 865 Carling Avenue, Suite 600, Ottawa, Ontario Canada, K1S 5S8 Email: requests@cadth.ca AccessionNumber 32015000819 Date abstract record published 30/06/2015 |